Sanofi’s Jevtana doubles progression-free survival in metastatic castration-resistant prostate cancer
October 1, 2019Manufacturing and Production, Research and Development ESMO 2019, Jevtana, Sanofi, pharma, prostate cancer
Sanofi was present at the 2019 European Society of Medical Oncology (ESMO) Congress in Barcelona this year to reveal new …
Chris Whitty begins role as England’s Chief Medical Officer
October 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
London consultant and public health professor, Chris Whitty, has begun his role as England’s Chief Medical Officer, taking over from …
Roche’s Tecentriq plus chemo shows promise in first-line, advanced bladder cancer
October 1, 2019Manufacturing and Production, Research and Development Cancer, ESMO 2019, Roche, breast cancer, pharma, tecentriq
Roche has revealed data from an interim analysis of its immunotherapy Tecentriq (atezolizumab) at the 2019 European Society for Medical …
AZ and MSD’s parp inhibitor Lynparza cuts risk of progression and death in prostate cancer
October 1, 2019Manufacturing and Production
AstraZeneca and MSD have shown in their Phase 3 PROfound trial, PARP inhibitor Lynparza (olaparib) reduced the risk of disease …
Sobi to acquire Dova for $915m to broaden hematology franchise
October 1, 2019Manufacturing and Production
Sobi is to buy Dova Pharmaceuticals for $915 million in a bid to grow Sobi’s hematology portfolio, with liver cancer …
ESMO studies show CD4K/6 inhibitor and fulvestrant improves OS in breast cancer
October 1, 2019Manufacturing and Production
Detailed findings from two Phase III trials presented at the European Society for Medical Oncology showed that treatment with a …
Pfizer CEO Albert Bourla to Succeed Ian Read as Executive Chairman
September 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Pfizer’s executive chairman Ian Read, is to be succeeded by CEO Albert Bourla with a date to start the post …
The world needs a better plan for cancer survival by 2030
September 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Roche, UN General Assembly, United Nations, feature, opinion, pharma
Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s …
AZ’s Tagrisso extends median overall survival by over 3 years in metastatic, EGFR-mutated lung cancer
September 30, 2019Research and Development, Sales and Marketing AstraZeneca, Cancer, ESMO 2019, Tagrisso, lung cancer, pharma
AstraZeneca took to the stage at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona to present new …
MSD’s Keytruda meets primary endpoint in triple-negative breast cancer
September 30, 2019Sales and Marketing
MSD have announced results from its Phase 3, KEYNOTE-522 trial that pathological complete response (pCR) in patients with early triple-negative …
Roche secures US paediatric approval for Rituxan in two rare forms of vasculitis
September 30, 2019Sales and Marketing MabThera, Rituxan, Roche, pharma, vasculitis
Roche has revealed that Rituxan (rituximab), also known as MabThera, has been awarded US approval from the FDA in combination …
Novartis reports positive Phase 3 PALLADIUM results in uncontrolled asthma
September 30, 2019Sales and Marketing
Novartis has announced that its investigational, once-daily, fixed-dose inhaled QMF149 (indacaterol acetate and mometasone furoate) was superior to mometasone furoate …
AZ and Merck’s ovarian cancer combo improves progression-free survival
September 30, 2019Sales and Marketing
AstraZeneca and Merck have announced that their combination treatment for newly diagnosed ovarian cancer significantly improved progression free survival. The …
Top Ten most popular articles on Pharmafile.com this week
September 27, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
Another week comes to a close, and it’s time to review the biggest stories of the week. Check out the …
Takeda’s Entyvio outperforms AbbVie’s Humira in moderate-to-severe ulcerative colitis
September 27, 2019Medical Communications, Research and Development AbbVie, Entyvio, Humira, Takeda, pharma, ulcerative colitis
Takeda has released strong new data for Entyvio (vedolizumab), showing that the gut-selective biologic outperformed AbbVie’s blockbuster anti-tumour necrosis factor-alpha …
AbbVie’s Mavyret scores FDA label expansion to shorten treatment duration for hepatitis C patients
September 27, 2019Medical Communications, Sales and Marketing AbbVie, FDA, hepatitis, hepatitis C, mavyret, pharma
The FDA has chosen to expand the existing label for AbbVie’s Mavyret (glecaprevir/pibrentasvir), it has been revealed, to include the …
FDA approves Genmab’s Darzalex combo in newly diagnosed multiple myeloma
September 27, 2019Medical Communications, Sales and Marketing FDA, Genmab, darzalex, pharma
Genmab’s CD38 inhibitor Darzalex (daratumumab) has been awarded marketing authorisation from the FDA in combination with bortezomib, thalidomide and dexamethasone …
Cell and Gene Therapy Catapult doubles capacity at UK site
September 26, 2019Manufacturing and Production, Medical Communications
The United Kingdom’s Cell and Gene Therapy Catapult (CGT Catapult) has added six additional modules of cleanroom space at its …
Male infertility linked to prostate cancer risk
September 26, 2019Research and Development
Research published in the British Medical Journal has found a link that men who have fertility treatment have a higher …
Iran reveals plans to domestically produce 135 strategic drugs
September 26, 2019Manufacturing and Production Iran, pharma, production
Iran has announced plans to promote self-sufficiency within the country with regard to its medicines production, with an aim of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
